TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration

While Brain-derived Neurotrophic Factor (BDNF) has long been implicated in treating neurological diseases, recombinant BDNF protein has failed in multiple clinical trials. In addition to its unstable and adhesive nature, BDNF can activate p75NTR, a receptor mediating cellular functions opposite to t...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Wei Guo, Keliang Pang, Yanbo Chen, Shudan Wang, Heng Li, Yihua Xu, Fang Han, Hongyang Yao, Hang Liu, Vanessa Lopes-Rodrigues, Dang Sun, Jingyu Shao, Jianying Shen, Yang Dou, Wen Zhang, He You, Wutian Wu, Bai Lu
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2019-12-01
Ráidu:	Neurobiology of Disease
Fáttát:	Receptor tyrosine kinase Neurotrophin BDNF TrkB signaling Agonistic antibody Monoclonal antibody
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S096999611930258X
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!